(Q69202752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

H Ujike

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

T Onoue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

K Akiyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

T Hamamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

S Otsuki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

number of pages

4

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

89-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00442011

30 September 2019

exact match

0 references

cites work

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

1 reference

12 December 2020

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

1 reference

12 December 2020

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

12 December 2020

The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic

1 reference

12 December 2020

Sensitization to cocaine stimulation in mice

1 reference

12 December 2020

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

12 December 2020

Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment

1 reference

12 December 2020

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

1 reference

12 December 2020

Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity

1 reference

12 December 2020

Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis

1 reference

12 December 2020

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

12 December 2020

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions

1 reference

12 December 2020

Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

1 reference

12 December 2020

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

1 reference

12 December 2020

Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors

1 reference

12 December 2020

An experimental study of onset and relapse mechanisms of the chronic methamphetamine psychosis (author's transl)

1 reference

12 December 2020

Substituted benzamide drugs as selective neuroleptic agents

1 reference

12 December 2020

Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

Amphetamine poisoning. Effectiveness of chlorpromazine

1 reference

12 December 2020

[3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system.

1 reference

12 December 2020

Enhanced stereotypies after repeated injections but not continuous amphetamines

1 reference

12 December 2020

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

12 December 2020

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

1 reference

12 December 2020

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

12 December 2020

[Continuous suppression of methamphetamine-induced supersensitivity by chronic haloperidol administration]

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00442011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2498964%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 September 2019

0 references

1 reference